These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 25149681
1. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response. Yan J, Tang D. Exp Cell Res; 2014 Oct 15; 328(1):132-142. PubMed ID: 25149681 [Abstract] [Full Text] [Related]
10. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition. Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. J Exp Clin Cancer Res; 2020 Oct 08; 39(1):213. PubMed ID: 33032653 [Abstract] [Full Text] [Related]
11. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, Konishi N. Prostate; 2003 Jun 01; 55(4):265-80. PubMed ID: 12712406 [Abstract] [Full Text] [Related]
12. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells. García V, Lara-Chica M, Cantarero I, Sterner O, Calzado MA, Muñoz E. Oncotarget; 2016 Jan 26; 7(4):4490-506. PubMed ID: 26683224 [Abstract] [Full Text] [Related]
14. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells. Acikgoz E, Guven U, Duzagac F, Uslu R, Kara M, Soner BC, Oktem G. PLoS One; 2015 Jan 26; 10(10):e0141090. PubMed ID: 26485709 [Abstract] [Full Text] [Related]
15. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. Gao W, Wang Y, Yu S, Wang Z, Ma T, Chan AM, Chiu PK, Ng CF, Wu D, Chan FL. Stem Cell Res Ther; 2022 May 07; 13(1):188. PubMed ID: 35526071 [Abstract] [Full Text] [Related]
16. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer. Yang DR, Ding XF, Luo J, Shan YX, Wang R, Lin SJ, Li G, Huang CK, Zhu J, Chen Y, Lee SO, Chang C. J Biol Chem; 2013 Jun 07; 288(23):16476-16483. PubMed ID: 23609451 [Abstract] [Full Text] [Related]
17. Upregulation of FAM84B during prostate cancer progression. Wong N, Gu Y, Kapoor A, Lin X, Ojo D, Wei F, Yan J, de Melo J, Major P, Wood G, Aziz T, Cutz JC, Bonert M, Patterson AJ, Tang D. Oncotarget; 2017 Mar 21; 8(12):19218-19235. PubMed ID: 28186973 [Abstract] [Full Text] [Related]